GlassScriptPhysician profile
Darren Peterson
NPI 1164538914
$51,040.13
in general payments reported to CMS, 2019-2025
14 companies · $4,636 in 2025
The $4,636 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $9,989 · 2021: $15K · 2022: $12K · 2023: $5,886 · 2024: $2,439 · 2025: $4,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $802 · Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,949.35 |
| Travel and Lodging | $801.84 |
| Food and Beverage | $209.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $28,996.41 | 2019-2024 | |
| Medtronic, INC. | $11,289.37 | 2021-2025 | Signia |
| Ethicon US, LLC | $6,779.22 | 2019-2025 | Linx Reflux Management System, Echelon Flex, Ethicon |
| Ethicon INC. | $2,202.37 | 2021-2022 | |
| Covidien LP | $1,602.14 | 2019-2020 | |
| Abbott Laboratories | $32.04 | 2019 | |
| Nestle Healthcare Nutrition INC. | $31.07 | 2022 | |
| Shire North American Group INC | $20.84 | 2019 | |
| Baudax Bio INC. | $20.39 | 2022 | |
| Baxter Healthcare | $16.50 | 2019 | |
| Apollo Endosurgery US INC | $13.13 | 2019 | |
| Currax Pharmaceuticals LLC | $12.84 | 2022 | |
| Novo Nordisk INC | $12.12 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.